|11.68||+0.76 / +6.96%|
Data as of 3:59pm ET
|11.68||0.00 / 0.00%|
The 5 analysts offering 12-month price forecasts for Avanir Pharmaceuticals Inc have a median target of 17.00, with a high estimate of 21.00 and a low estimate of 15.00. The median estimate represents a +45.55% increase from the last price of 11.68.
The current consensus among 5 polled investment analysts is to Buy stock in Avanir Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.